Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian P Gee

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|July 5, 2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferCatherine M Bollard, Stephen Gottschalk, Ann M Leen, et al.
Cytotherapy|June 8, 2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceAdrian P Gee, Sara Richman, April Durett, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Transfusion|October 16, 2014
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) programRobert W Lindblad, Laarni Ibenana, John E Wagner, et al.
Blood|October 27, 2005
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationRaphaël F Rousseau, Ettore Biagi, Aurélie Dutour, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Blood|August 25, 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationAnn M Leen, Anne Christin, Gary D Myers, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
The Journal of Clinical Investigation|August 15, 2017
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytesCarlos A Ramos, Brandon Ballard, Huimin Zhang, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Nature Medicine|November 4, 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaMartin A Pule, Barbara Savoldo, G Doug Myers, et al.
Blood|July 5, 2007
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transferCatherine M Bollard, Stephen Gottschalk, Ann M Leen, et al.
Cytotherapy|June 8, 2010
Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experienceAdrian P Gee, Sara Richman, April Durett, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Transfusion|October 16, 2014
Cell therapy product administration and safety: data capture and analysis from the Production Assistance for Cellular Therapies (PACT) programRobert W Lindblad, Laarni Ibenana, John E Wagner, et al.
Blood|October 27, 2005
Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantationRaphaël F Rousseau, Ettore Biagi, Aurélie Dutour, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Blood|August 25, 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantationAnn M Leen, Anne Christin, Gary D Myers, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
The Journal of Clinical Investigation|August 15, 2017
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytesCarlos A Ramos, Brandon Ballard, Huimin Zhang, et al.
Pageof 9